[1]
S. D. Patel and E. G. Mitchell, “HYPERPARATHYROIDISM-INDUCED ERYTHROPOIETIN RESISTANCE: IMPLICATIONS FOR CKD MANAGEMENT”, IRJPS, vol. 8, no. 3, pp. 1–8, Oct. 2023.